Cargando…

Infliximab Combined with Enteral Nutrition for Managing Crohn's Disease Complicated with Intestinal Fistulas

Aim. This study was performed to evaluate the additional enteral nutrition (EN) in the efficacy of infliximab (IFX) compared with the conventional therapy in managing Crohn's disease (CD) complicated with intestinal fistulas. Methods. A total of 42 CD with intestinal fistulas were randomly divi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiao-Li, Chen, Ren-Pin, Tao, Li-Ping, Wu, Jian-Sheng, Chen, Xiang-Rong, Chen, Wei-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055994/ https://www.ncbi.nlm.nih.gov/pubmed/27738427 http://dx.doi.org/10.1155/2016/5947926

Ejemplares similares

Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn's Disease
por: Luo, Youyou, et al.
Publicado: (2017)

Impaired Coagulation Status in the Crohn's Disease Patients Complicated with Intestinal Fistula
por: Li, Yuan, et al.
Publicado: (2018)

Effectiveness of Concomitant Enteral Nutrition Therapy and Infliximab for Maintenance Treatment of Crohn’s Disease in Adults
por: Hirai, Fumihito, et al.
Publicado: (2012)

Fistuloclysis Improves Liver Function and Nutritional Status in Patients with High-Output Upper Enteric Fistula
por: Wu, Yin, et al.
Publicado: (2014)

Outcomes of Pediatric Patients with Crohn's Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission
por: Lv, Yao, et al.
Publicado: (2022)

Infliximab for Crohn’s Disease Patients with Perianal Fistulas: Better Image, Better Life
por: Hong, Liwen, et al.
Publicado: (2020)

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease
por: Gu, Bonita, et al.
Publicado: (2022)

Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy
por: Cao, Wan-Ting, et al.
Publicado: (2022)

Exclusive enteral nutrition remodels the intestinal flora in patients with active Crohn's disease
por: Jiang, Jingjing, et al.
Publicado: (2022)

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
por: Im, Jong Pil
Publicado: (2017)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

An overview of the role of exclusive enteral nutrition for complicated Crohn’s disease
por: Adamji, Mustafa, et al.
Publicado: (2019)

Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
por: Jeong, Seong Yeon, et al.
Publicado: (2014)

A novel role of the splenic volume in Crohn’s disease: evaluating the efficacy of infliximab
por: Shi, Xuan, et al.
Publicado: (2023)

Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China
por: Shi, Ji-Hao, et al.
Publicado: (2020)

The Efficacy of Infliximab Monotherapy versus Infliximab-Azathioprine Sequential Treatment in Crohn's Disease: Experience from a Tertiary Medical Center in China
por: Zhang, Tianyu, et al.
Publicado: (2016)

Oral exclusive enteral nutrition induces mucosal and transmural healing in patients with Crohn’s disease
por: Chen, Jia-Min, et al.
Publicado: (2019)

Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
por: Lee, Jong Lyul
Publicado: (2019)

Efficacy of infliximab treatment on the mucosal healing of different intestinal segments in patients with ileocolonic Crohn’s disease
por: Wu, Yaling, et al.
Publicado: (2020)

Early intestinal obstruction after infliximab therapy in Crohn’s disease
por: Chiba, Mitsuro, et al.
Publicado: (2019)

Intestinal tuberculosis previously mistreated as Crohn’s disease and complicated with perforation: a case report and literature review
por: Wu, Yu-Feng, et al.
Publicado: (2015)

Infliximab Extends the Duration until the First Surgery in Patients with Crohn's Disease
por: Sakatani, Aki, et al.
Publicado: (2013)

Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile
por: Medrano, Luz María, et al.
Publicado: (2015)

Brain Abscesses in Crohn’s Disease as a Complication of Infliximab Therapy
por: Mansour, Mahmoud M, et al.
Publicado: (2021)

Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020)

Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
por: Sharma, Sanchit, et al.
Publicado: (2021)

Maintenance of Remission with Partial Enteral Nutrition Therapy in Pediatric Crohn's Disease: A Retrospective Study
por: Schulman, Jacqueline M., et al.
Publicado: (2017)

Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease
por: de Bruyn, Jessica R., et al.
Publicado: (2018)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

A novel role of prognostic nutritional index in predicting the effectiveness of infliximab in Crohn's disease
por: Peng, Ziheng, et al.
Publicado: (2023)

Systemic lupus erythematosus complicated by Crohn’s disease with rectovaginal fistula
por: Yeh, Heng, et al.
Publicado: (2021)

Enteral Nutrition in Crohn's Disease: An Underused Therapy
por: Kansal, S., et al.
Publicado: (2013)

Enteral fistula as initial manifestation of primary intestinal lymphoma
por: Zhao, Rui-Jie, et al.
Publicado: (2020)

Recurrent pneumonia and colobronchial fistula from Crohn’s disease: Infliximab alters and simplifies surgical management
por: Mercadal, Nuria Rosa, et al.
Publicado: (2012)

Crohn’s disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report
por: Xiao, Lin, et al.
Publicado: (2021)

Infliximab therapy for Crohn’s-like disease in common variable immunodeficiency complicated by massive intestinal hemorrhage: a case report
por: Akazawa, Yuko, et al.
Publicado: (2014)

Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease
por: Kowalska-Duplaga, Kinga, et al.
Publicado: (2020)

The impact of medication belief on adherence to infliximab in patients with Crohn’s disease
por: Li, Shuyan, et al.
Publicado: (2023)

Role of perioperative nutritional status and enteral nutrition in predicting and preventing post-operative complications in patients with Crohn’s disease
por: Jiang, Tianyu, et al.
Publicado: (2023)

Clinical features of enteric and colo-duodenal fistula in patients with Crohn’s disease
por: Lee, Jun Su, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0pk4s4r0jcpvoqv2dbjm3rp747